Completed NA INTERVENTIONAL 1-arm NCT04588064

18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma

Comparison of 18F-FDG and 68Ga-FAPI PET/CT in Patients with Lung Adenocarcinoma

Sponsor: The First Affiliated Hospital of Xiamen University

Conditions 18F-FDG 68Ga-FAPI Lung Adenocarcinoma PET/CT

Updated 6 times since 2020 Last updated: Jan 26, 2025 Started: Jul 1, 2020 Primary completion: Jul 1, 2022 Completion: Jul 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04588064, this NA trial focuses on 18F-FDG and 68Ga-FAPI and remains completed. Sponsored by The First Affiliated Hospital of Xiamen University, it has been updated 6 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Feb 2025 — Present [monthly]

Completed NA

Status: Unknown → Completed
Sep 2024 — Feb 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Nov 2022 [monthly]

Recruiting NA

▶ Show 1 earlier version

Nov 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Jul 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The First Affiliated Hospital of Xiamen University

Data source: The First Affiliated Hospital of Xiamen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xiamen, China